Phellopterin Inhibits Inflammation and Relieves Cartilage Degradation by Suppressing MAPK Signaling in Osteoarthritis
The FASEB Journal · 31.03.2026 · 40 (6)
DOI: 10.1096/fj.202504376r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 23.03.2026. Verfasst von Chao Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Joint Surgery, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong, China. Hauptthemen laut MEDLINE: Osteoarthritis, Inflammation, MAP Kinase Signaling System, Cartilage, Articular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Osteoarthritis (OA) is thought to be the most common joint disorder and a major cause of disability and socioeconomic burden worldwide. Phellopterin has been demonstrated to exert anti‐inflammatory effects in various diseases. However, the function of phellopterin in OA remains unclear. In this study, we aimed to investigate the role and mechanism of action of phellopterin in OA. We found that phellopterin promoted the proliferative ability and repressed the apoptotic ability of interleukin‐1β (IL‐1β)‐treated ATDC5 cells. Our data also confirmed that phellopterin relieved inflammatory mediators release and extracellular matrix (ECM) degradation in vitro. In vivo, phellopterin significantly attenuated cartilage degradation and inflammation in OA rats. Moreover, we demonstrated that phellopterin could inhibit the activation of mitogen‐activated protein kinase (MAPK) signaling pathway in both IL‐1β‐induced ATDC5 cells and OA rats. Rescue experiment results revealed that overexpression of extracellular signal‐regulated kinase, c‐Jun N‐terminal kinase, or p38 MAPK reversed the influences of phellopterin on the proliferation, apoptosis, inflammatory mediators release, and ECM degradation in IL‐1β‐treated ATDC5 cells. Collectively, these findings demonstrated that phellopterin could inhibit inflammatory response and ameliorate cartilage degradation by suppressing MAPK signaling pathway in OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Joint Surgery, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong, China.
ORCID-Profile: Bo Liu
Zitieren
APA
Sun, C., Wang, Y., Zhang, K., & Liu, B. (2026). Phellopterin Inhibits Inflammation and Relieves Cartilage Degradation by Suppressing MAPK Signaling in Osteoarthritis. The FASEB Journal, 40(6). https://doi.org/10.1096/fj.202504376r
Vancouver
Sun C, Wang Y, Zhang K, Liu B. Phellopterin Inhibits Inflammation and Relieves Cartilage Degradation by Suppressing MAPK Signaling in Osteoarthritis. The FASEB Journal. 2026;40(6). doi:10.1096/fj.202504376r
BibTeX
@article{Sun2026,
author = {Sun, Chao and Wang, Yexin and Zhang, Kai and Liu, Bo},
title = {Phellopterin Inhibits Inflammation and Relieves Cartilage Degradation by Suppressing MAPK Signaling in Osteoarthritis},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {6},
doi = {10.1096/fj.202504376r}
}
EUVIMED